CB Insights
Technology Market Intelligence
Technology Market Intelligence
Public list: Pharma Startups (6570)
Proacta is a clinical-stage, biopharmaceutical company focused on addressing unmet needs in the field of cancer with current efforts directed towards the development of hypoxia-activated prodrugs that target treatment-resistant cancer cells.
Company (Alive / Active)
Phone: 858-642-0386
4275 Executive Square
Suite 440
La Jolla, 92037
California, United States
| Total Funding | Date of Last Funding | |
|---|---|---|
| Proacta | $49.1M | Dec 23, 2011 |
| See all 14 competitors | ||
| Per Week | Per Month | Per 6 Months | Per Year | |
|---|---|---|---|---|
| Rank | Login to see details | |||
| Page Views Per Million | Login to see details | |||
| Page Views Per User | Login to see details | |||
| Reach Per Million | Login to see details | |||
| Investor | Investor Type | Location | Participating Rounds |
|---|---|---|---|
| Delphi Ventures | Venture Capital | Menlo Park, California, United States | Debt, Series B |
| Alta Partners | Venture Capital | San Francisco, California, United States | Convertible Note, Debt, Series B, Series A |
| GBS Venture Partners | Venture Capital | Australia | Convertible Note, Debt, Series B, Series A |
| Clarus | Venture Capital | Cambridge, Massachusetts, United States | Convertible Note, Debt, Series B |
| Endeavour Capital | Private Equity | Portland, Oregon, United States | Debt, Series B, Series A |
| Title | Application Date | Patent Date | Status (Patent / Application) |
|---|
